Susceptibility of HLA DR3 transgenic mice to experimental autoimmune myasthenia gravis.
Raju
R
R
Department of Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Zhan
W Z
WZ
Karachunski
P
P
Sieck
G C
GC
Conti-Fine
B M
BM
David
C S
CS
D000818:Animals; D001323:Autoantibodies / Q000097:blood; D004198:Disease Susceptibility; D004557:Electric Organ; D015803:HLA-DR3 Antigen / Q000096:biosynthesis* / Q000235:genetics; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009157:Myasthenia Gravis / Q000235:genetics / Q000276:immunology* / Q000503:physiopathology; D009469:Neuromuscular Junction / Q000503:physiopathology; D011950:Receptors, Cholinergic / Q000276:immunology; D014101:Torpedo
D001323:Autoantibodies; D015803:HLA-DR3 Antigen; D011950:Receptors, Cholinergic